Mycobacterial immunotherapy for prostate cancer: where can we go from here?

Nat Rev Urol. 2020 Apr;17(4):189-190. doi: 10.1038/s41585-020-0283-2.

Vasilis Stavrinides^{1

2}, Angus Dalgleish³, John P Copier³, Caroline M Moore^{4

5}

¹ Division of Surgery and Interventional Science, University College London, London, UK. [email protected].
² Department of Urology, University College London Hospital NHS Foundation Trust, London, UK. [email protected].
³ Oncology Group, Institute of Infection and Immunity, St George's University of London, London, UK.
⁴ Division of Surgery and Interventional Science, University College London, London, UK.
⁵ Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.

No abstract available

Publication types